Careers
Contact
Menu
Skip to content
Company
Our Vision & Mission
Our People
Our Leadership
Board of Directors
Manufacturing
Affiliations
Investors
News & Events
Events Calendar
Presentations
Financials
Fundamentals
Stock
Historical Price Lookup
Investment Calculator
Ownership Summary
Estimates
Governance
Board of Directors
Committee Composition
Shareholder Services
Email Alerts
Pipeline
Platforms
Immuno-Oncology Assets
G-MABs™
CAR-T
ADCs
iTAbs
Oncolytic Virus
Pain Management Assets
ZTlido™
RTX
Translational Efficiencies
Warning
: DOMDocument::load() [
domdocument.load
]: Document is empty in http://sorrentotherapeutics.mediaroom.com/api/newsfeed_releases/get.php?id=122589, line: 1 in
/home/sorren8/public_html/wp-content/themes/sorrento/news_display.php
on line
10
Press Releases
« Back to News
MENU
Company
Our Vision & Mission
Our People
Our Leadership
Board of Directors
Manufacturing
Affiliations
Investors
News & Events
Events Calendar
Presentations
Financials
Fundamentals
Stock
Historical Price Lookup
Investment Calculator
Ownership Summary
Estimates
Governance
Board of Directors
Committee Composition
Shareholder Services
Email Alerts
Pipeline
Platforms
Immuno-Oncology Assets
G-MABs™
CAR-T
Antibody Drug Conjugates (ADCs)
iTAbs
Oncolytic Virus
Pain Management Assets
RTX
ZTlido™
Translational Efficiencies
Careers
Contact